InterventionsHuman trial
Efficacy and Safety of Bofanglutide (GZR18), a Biweekly GLP-1RA, Compared with Semaglutide in Chinese Patients with T2D
ADA Scientific Sessions 2025 Abstract
The paper
Haiya Wu, Ming Liu, Zhifeng Cheng, Zhong-Ru Gan
Show 13 more authors
Lu Li, Cai H, J. M. Liu, Jinling Liu, Yifeng Zheng, Su Wang, Jing Zhao, Wei Yang, Tian Xie, Yue Li, Anshun He, Spencer Carter, Wei Chen,Bridgewater
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Poster 752-P